The BioScience team continues to explore the development and production of new heparin derivatives. This includes low molecular weight heparins, heparinized compounds for medical device and biomaterial applications, and heparin derivatives for novel medical applications. Research and development (R&D) capabilities also include using fermentation and chemoenzymatic reactions to produce glycosaminoglycans.
VIEW HEPARIN PRODUCTS